IL81030A0 - Aqueous solutions containing organic anions,for fluid therapy - Google Patents

Aqueous solutions containing organic anions,for fluid therapy

Info

Publication number
IL81030A0
IL81030A0 IL81030A IL8103086A IL81030A0 IL 81030 A0 IL81030 A0 IL 81030A0 IL 81030 A IL81030 A IL 81030A IL 8103086 A IL8103086 A IL 8103086A IL 81030 A0 IL81030 A0 IL 81030A0
Authority
IL
Israel
Prior art keywords
aqueous solutions
fluid therapy
containing organic
solutions containing
organic anions
Prior art date
Application number
IL81030A
Other languages
English (en)
Original Assignee
Veech Richard L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25205036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL81030(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Veech Richard L filed Critical Veech Richard L
Publication of IL81030A0 publication Critical patent/IL81030A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL81030A 1985-12-18 1986-12-18 Aqueous solutions containing organic anions,for fluid therapy IL81030A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81091885A 1985-12-18 1985-12-18

Publications (1)

Publication Number Publication Date
IL81030A0 true IL81030A0 (en) 1987-03-31

Family

ID=25205036

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81030A IL81030A0 (en) 1985-12-18 1986-12-18 Aqueous solutions containing organic anions,for fluid therapy

Country Status (11)

Country Link
US (1) US5100677A (xx)
EP (1) EP0249667B2 (xx)
JP (1) JPS63502274A (xx)
CN (1) CN86108978A (xx)
AT (1) ATE80303T1 (xx)
AU (4) AU6776887A (xx)
DE (1) DE3686718T3 (xx)
ES (1) ES2052495T5 (xx)
GR (1) GR3006492T3 (xx)
IL (1) IL81030A0 (xx)
WO (1) WO1987003808A1 (xx)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38604E1 (en) * 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
US5719119A (en) * 1985-12-18 1998-02-17 British Technology Group, Ltd. Parenteral nutrition therapy with amino acids
FR2619715A1 (fr) * 1987-08-25 1989-03-03 Bayle Francois Serum glucose polyionique iso-osmotique
US5310768A (en) * 1987-10-29 1994-05-10 Ab Erik Vinnars Method for improving the glutamine content in skeletal muscle and composition therefore
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US5112622A (en) * 1990-01-19 1992-05-12 Kopp Klaus F Intravenous solutions for influencing renal function and for maintenance therapy
EP0658353A1 (de) * 1993-11-19 1995-06-21 Bertold Dr. Reinhardt Pyruvathaltige CAPD- und Substitutionslösungen sowie pyruvathaltige Dialysierflüssigkeiten
JP3636468B2 (ja) * 1994-07-01 2005-04-06 バクスター、インターナショナル、インコーポレイテッド 生化学的にバランスさせた腹膜透析溶液
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US6417231B1 (en) 1996-12-23 2002-07-09 Frank L. Greenway Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US6846842B2 (en) * 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
WO2002096374A2 (en) * 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
EP1494659B1 (en) * 2002-04-17 2005-10-12 Critical Therapeutics, Inc. Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
US7445801B2 (en) 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
IL151169A0 (en) * 2002-08-09 2003-04-10 Talgon Invest Ltd A peritoneal dialysis solution
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
NZ543201A (en) * 2003-05-01 2007-05-31 Innogene Kalbiotech Pte Ltd Lactate containing pharmaceutical composition and uses thereof
US7132221B2 (en) * 2003-09-12 2006-11-07 Headway Technologies, Inc. Method to print photoresist lines with negative sidewalls
ES2246690B1 (es) * 2004-03-30 2007-04-01 Jose Luis Pelluz Garcia Composicion de plasma sanguineo.
ES2246691B1 (es) * 2004-03-30 2007-04-01 Jose Luis Dieter De Shart, S.L. Composicion de acido l(+)-lactico de origen natural y organico.
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US7947736B2 (en) 2004-07-16 2011-05-24 Btg International Limited Oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
WO2006098767A2 (en) * 2004-09-21 2006-09-21 Ketocytonyx Inc. Treatment of adhd
US20070281892A1 (en) * 2004-09-21 2007-12-06 Martin Keith F Dopaminergic Mimetics
US7935070B2 (en) 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
US20090285909A1 (en) * 2006-04-03 2009-11-19 Leverve Xavier M Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof
JP2010523714A (ja) 2007-04-12 2010-07-15 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 虚血／再灌流保護組成物および使用法
US7754247B2 (en) * 2007-05-29 2010-07-13 University Of South Carolina Resuscitation fluid
US20120064178A1 (en) * 2010-09-13 2012-03-15 Carolyn Flora Anne Dean Cell-8 Solution
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
US8557301B2 (en) * 2011-07-01 2013-10-15 Drip Drop, Inc. Oral rehydration composition
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10596131B2 (en) 2017-11-22 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US10292952B2 (en) * 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10245242B1 (en) 2017-11-22 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10596130B2 (en) 2017-12-19 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US10596129B2 (en) 2017-11-22 2020-03-24 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10245243B1 (en) 2017-12-19 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US10307398B2 (en) 2016-09-20 2019-06-04 Regents Of The University Of Minnesota Resuscitation composition and methods of making and using
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US10925843B2 (en) * 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
WO2023281034A1 (en) * 2021-07-08 2023-01-12 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to treat acidosis related diseases with acetoacetate
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993750A (en) * 1974-12-20 1976-11-23 Research Corporation Aqueous hypertonic solution and compositions useful for preparation of same
US4308255A (en) * 1980-03-24 1981-12-29 Haemophor Corporation Balanced oncotic pressure fluid
DE3273611D1 (en) * 1982-11-10 1986-11-13 Laevosan Gmbh & Co Kg Infusion solutions for heart therapy
IT1214872B (it) † 1984-04-06 1990-01-18 Mariano Feriani Sacca contenente due o piu'sostanze per infusione ad uso medicale, poste in scomparti separati, comprendente mezzi atti a consentire la miscelazione di tali sostanze solo al momento dell'uso.
US4663166A (en) * 1984-06-22 1987-05-05 Veech Richard L Electrolyte solutions and in vivo use thereof

Also Published As

Publication number Publication date
EP0249667A1 (en) 1987-12-23
JPS63502274A (ja) 1988-09-01
AU6066994A (en) 1994-06-23
GR3006492T3 (xx) 1993-06-21
US5100677A (en) 1992-03-31
ATE80303T1 (de) 1992-09-15
DE3686718T2 (de) 1993-04-22
AU6776887A (en) 1987-07-15
CN86108978A (zh) 1987-11-04
EP0249667B2 (en) 2004-12-29
ES2052495T5 (es) 2005-07-16
DE3686718D1 (de) 1992-10-15
AU2488097A (en) 1997-08-21
AU6855890A (en) 1991-03-14
ES2052495T3 (es) 1994-07-16
DE3686718T3 (de) 2005-11-17
WO1987003808A1 (en) 1987-07-02
EP0249667B1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
IL81030A0 (en) Aqueous solutions containing organic anions,for fluid therapy
IL90052A (en) :-substituted 4-(quinolin- 2-yl-methoxy) phenylacetic acids and esters, their preparation and pharmaceutical compositions containing them
CS782686A2 (en) Method of benzimidazole derivatives production
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
DK0414078T3 (da) Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater
AU635305B2 (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
AU2861389A (en) Disubstituted pyridines
IL97795A0 (en) Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles,their preparation and pharmaceutical compositions containing them
CA2002472A1 (en) Liquid oral formulation
NO870941D0 (no) Vandige preparater med fytotoksisk virkning.
AU7071487A (en) Chlorpheniramine therapy
AU8678682A (en) Aminoglycoside derivatives
CS103587A2 (en) Fungicide,especially for the wood protection
DK89289D0 (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
IT1204069B (it) Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
CA1010787A (en) Composition for the control of slime in aqueous systems comprising 2,2-dibromo-3-nitrilopropionamide and t-butylhydroperoxide
ES8707512A1 (es) Procedimiento para preparar 6-etoxi-4-metil-benzotiazol-2 (3h)-ona
AU2002320666A1 (en) Fluid Therapy with L-lactate and/or Pyruvate Anions